Could loanDepot's (LDI) Servicing Platform Be the Key to Unlocking Hidden Value?

• Earlier this week, Citron Research released a bullish report highlighting loanDepot’s servicing portfolio and credit quality, asserting the company may be undervalued given the strengths of its servicing platform and refinancing operations.
• The analysis pointed to a 70% recapture rate and suggested loanDepot’s servicing portfolio value could exceed the company’s current market capitalization.
• We’ll explore how this renewed focus on loanDepot’s servicing business could reshape the company’s investment narrative and future projections.

We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

loanDepot Investment Narrative Recap

To be a loanDepot shareholder, you need to believe that its large, high-quality servicing portfolio and resilient refinancing platform can support sustained value, offering a buffer in volatile mortgage markets. The recent Citron Research report spotlighted these strengths and appeared to jumpstart a significant share price rally; however, while it draws short-term attention to the servicing business, the company's ongoing profitability challenges remain the key catalyst, and also the biggest risk, in the near term, outweighing any immediate positive sentiment from the news event.

Of the latest announcements, loanDepot’s Q2 2025 results are especially relevant, with the company showing a reduced net loss compared to the previous year. While this continued improvement in losses may encourage some optimism, it does not alter the fundamental risk that persistent unprofitability could pressure both valuation and investor confidence, even with favorable coverage or temporary market boosts.

By contrast, investors should also be aware that recurring net losses remain a material challenge for the company and...

Read the full narrative on loanDepot (it's free!)

loanDepot's outlook anticipates $1.8 billion in revenue and $80.2 million in earnings by 2028. This is based on a projected 16.4% annual revenue growth rate and a $147.3 million increase in earnings from the current level of -$67.1 million.

Uncover how loanDepot's forecasts yield a $1.62 fair value, a 54% downside to its current price.

Exploring Other Perspectives

Fair value estimates from four Simply Wall St Community members range from US$1.62 to US$233.72 per share. These diverse views sit against a backdrop of ongoing unprofitability, urging you to consider a full spectrum of outlooks when weighing loanDepot’s future.

Explore 4 other fair value estimates on loanDepot - why the stock might be worth less than half the current price!

Build Your Own loanDepot Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your loanDepot research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free loanDepot research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate loanDepot's overall financial health at a glance.

Looking For Alternative Opportunities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• These 9 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com